CROI 2015 Program and Abstracts

General Information

ABSTRACTS

General Information

Scientific Categories A Virology

Common Reasons for Abstract Rejection • Information is not new enough • Methodology is inadequate or insufficient to support conclusions • Background does not summarize the hypothesis; submission is poorly written • Abstract is duplicative of other submissions

B Molecular Epidemiology and HIV/SIV Evolution C Pathogenesis: Human Studies and Animal Models

(D Pathogenesis: Animal Models has been combined with category C) E Host Immune Responses to Infection, Vaccines, and Immunotherapy F HIV Persistence, Reservoirs, Latency, Eradication, Including Gene Therapy G Neuropathogenesis H Clinical Pharmacology I Antiretroviral Therapy: Preclinical Studies

• Abstract is not appropriate for CROI • Controls are absent or inadequate • Statistical evaluation is inadequate or absent

• Summary of essential results is inadequate or absent • Data are inadequate or insufficient to support conclusions • Submission reports clinical trial and data from unplanned analysis or incomplete or ongoing studies • Format does not follow guidelines (eg, section[s] missing, more than 1 graphic, table, or figure submitted) Statistics

J Antiretroviral Therapy: Randomized Clinical Trials K Antiretroviral Therapy: Observational Studies L HIV Drug Resistance

M HIV Diagnostics N Hepatitis Viruses O HIV‐Related and Non–HIV‐Related Malignancies P Cardiovascular Complications of HIV Q Other Complications of HIV Infection and Antiretroviral therapy R Tuberculosis and Other Opportunistic Infections S HIV inWomen andWomen’s Health T Maternal/Fetal HIV U Pediatrics and Adolescents V Prevention and Intervention Studies W Epidemiology X Health Care Delivery and Health Systems Y Implementation Science Z Population and Economic Modeling Abstract Content Author names, institutions, abstract titles, and abstracts in the Program and Abstracts eBook are generally presented as submitted by the corresponding author. Abstract Review Process The PC and a panel of external reviewers reviewed the more than 1900 submitted abstracts. Each abstract was scored by 5 to 10 reviewers selected for each abstract category based upon their individual expertise. PC members and external experts in the field reviewed the abstracts for the quality and originality of the work and scored them numerically. All reviewers were instructed to abstain from scoring any abstract on which they are an author or coauthor, have a financial or personal conflict of interest, or do not have the appropriate expertise to evaluate. Scores for each abstract were averaged and the standard deviation was calculated to assess variability. If variability was high, outlier scores are identified and censored. Abstracts with high variability in scores were discussed individually during a series of conference calls.

Abstracts

Total general abstracts submitted: Total general abstracts accepted:

1921 1016

General oral abstracts: General poster abstracts:

95

921

Total late-breaker abstracts submitted:

195

Total late-breaker accepted: Late-breaker oral abstracts: Late-breaker poster abstracts:

43 24 19

Total abstracts submitted: Total abstracts accepted:

2116 1059

165

Submitted Abstracts Africa

28

100

165 9% 100 5% 28 1%

Asia Afri Asia Australia Europe Latin & South America North America Australia

1057

502

Europe 502 26% Latin & South America 64 3% North America 1057 55%

64

xviii

CROI 2015